DEPOCYT vs XELODA

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 23, 2026·How we rate

Possible drug interaction. DEPOCYT and XELODA are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	DEPOCYT	XELODA
Rating	70/100	New
Pharmacy pays	—	~$14.21 /30
Type	RX	RX
Active ingredient	CYTARABINE	CAPECITABINE
Manufacturer	Pacira Pharms Inc	Cheplapharm
Dosage forms	Injectable, Liposomal	Tablet
Drug class	Nucleoside Metabolic Inhibitor	Nucleoside Metabolic Inhibitor
Boxed warning	None	Boxed warning
Treats	Leukemia, Lymphoma, Meningeal Neoplasms	Breast Neoplasms, Colorectal Neoplasms

depocyt xeloda

Rating

70/100

New

Pharmacy pays

—

~$14.21 /30

Type

Active ingredient

CYTARABINE

CAPECITABINE

Manufacturer

Pacira Pharms Inc

Cheplapharm

Dosage forms

Injectable, Liposomal

Tablet

Drug class

Nucleoside Metabolic Inhibitor

Boxed warning

None

Boxed warning

Treats

Leukemia, Lymphoma, Meningeal Neoplasms

Breast Neoplasms, Colorectal Neoplasms

Frequently asked questions

What is the difference between Depocyt and Xeloda?

Depocyt contains Cytarabine, while Xeloda contains Capecitabine — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.